Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Dallas, TX
SEC filing record 1 source field available
Fiscal year end
31 December
Lantern Pharma Inc. has filed 255 SEC EDGAR filings since 14 Jan 2019

SEC filing history

Showing 176-200 of 255 matching filings.

Per page
25
Current page
8
10-Q File 001-39318

QUARTERLY REPORT

Filing date
03 May 2021
Reporting date
31 Mar 2021
Next action
Verify source filing
DEFA14A File 001-39318

DEFINITIVE ADDITIONAL MATERIALS

Filing date
09 Apr 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-39318

DEFINITIVE PROXY STATEMENT

Filing date
09 Apr 2021
Reporting date
19 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-39318

ANNUAL REPORT

Filing date
10 Mar 2021
Reporting date
31 Dec 2020
Next action
Verify source filing
8-K File 001-39318

CURRENT REPORT

Filing date
10 Mar 2021
Reporting date
10 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-91536

SC 13G

Filing date
16 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-91536

SC 13G

Filing date
16 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-91536

LANTERN PHARMA INC.

Filing date
25 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
19 Jan 2021
Reporting date
14 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-251992

PROSPECTUS SUPPLEMENT

Filing date
15 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1MEF File 333-252116

REGISTRATION STATEMENT

Filing date
15 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-251992

EFFECT filing

Filing date
14 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
11 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
FWP File 333-251992

FREE WRITING PROSPECTUSES

Filing date
11 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
08 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1 File 333-251992

REGISTRATION STATEMENT

Filing date
08 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39318

CURRENT REPORT

Filing date
06 Jan 2021
Reporting date
30 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
21 Dec 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DRS File 377-03896

DRS filing

Filing date
16 Dec 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DRSLTR

DRSLTR filing

Filing date
15 Dec 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-39318

QUARTERLY REPORT

Filing date
29 Oct 2020
Reporting date
30 Sep 2020
Next action
Verify source filing
8-K File 001-39318

CURRENT REPORT

Filing date
29 Oct 2020
Reporting date
29 Oct 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39318

CURRENT REPORT

Filing date
21 Aug 2020
Reporting date
19 Aug 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39318

CURRENT REPORT

Filing date
30 Jul 2020
Reporting date
30 Jul 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-39318

QUARTERLY REPORT

Filing date
30 Jul 2020
Reporting date
30 Jun 2020
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .